Highlights,Welch Group LLC reduced its position in Pfizer,(NYSE:PFE),by over 35% in the fourth quarter.,Institutional ...

Bernstein analyst Courtney Breen maintained a Hold rating on Pfizer (PFE – Research Report) yesterday and set a price target of $32.00. The ...

HonorHealth announced the creation of its new international Center for Translational Science. Sanofi said it will repurchase $5.2 billion of stock and grow profits faster this year as the drugmaker ...

Analyst Tim Anderson from Bank of America Securities reiterated a Hold rating on Pfizer (PFE – Research Report) and keeping the price target at ...

An analysis of ctDNA testing for early detection of recurrence showed that test had high sensitivity across multiple sites of recurrence, including liver (96%), lymph nodes (89%), abdominopelvic (86%) ...

An immunotherapy combination for advanced, highly mutated colorectal cancer (CRC) significantly slowed disease progression ...

24 The study of red-cell survival†Supplied through the courtesy of Dr. David R. Chisholm, Charles Pfizer and Company, Groton, Connecticut. ‡Cal Biochem, Los Angeles, California. J.R., a 45 ...

Others generate consistent and reliable dividends over the long run. Chevron (NYSE: CVX) has increased its dividend for 37 consecutive years. The oil and gas producer doesn't just have an impressive ...

Income investors should love Pfizer's forward dividend yield of 6.51%. Two cousins, Charles Pfizer and Charles Erhart, founded Pfizer in 1849. The company is now one of the world's largest ...